Hepatitis C virus in the setting of HIV or hepatitis B virus coinfection

Seminars in Liver Disease
Richard K Sterling, Mark S Sulkowski

Abstract

Because of shared routes of transmission, coinfection with hepatitis C virus (HCV) or hepatitis B virus (HBV), or both, is common among HIV-infected persons, affecting approximately 15 to 30% and 10 to 15% of patients, respectively. Advances in antiretroviral therapy have improved the life expectancy of patients infected with HIV, and, as a consequence, HCV-related liver disease has emerged as a significant comorbid disease among such patients. Concurrent HIV infection may be associated with higher serum HCV RNA levels, accelerated progression of hepatic fibrosis, increased risk of end-stage liver disease, hepatocellular carcinoma and death among persons coinfected with hepatitis C. Similarly, coinfection with HCV and HBV may lead to more severe liver disease and greater risk of hepatocellular carcinoma (HCC) than does HCV infection alone. Although definitive randomized controlled trials are not yet completed, current guidelines recommend the use of pegylated interferon alfa plus ribavirin for the treatment of chronic HCV in eligible HIV-infected persons. Conversely, the optimal treatment of chronic HCV in persons with chronic HBV infection has not been defined but may include pegylated interferon alfa plus ribavirin, with or w...Continue Reading

Citations

Mar 16, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brian R EdlinVictoria A Cargill
Aug 9, 2006·Current Opinion in Oncology·Liron PantanowitzBruce J Dezube
Sep 9, 2006·Annual Review of Medicine·Roger G Ulrich
Sep 15, 2005·Annals of Clinical Microbiology and Antimicrobials·Seth D Crockett, Emmet B Keeffe
Dec 14, 2011·International Journal of Hepatology·Marcello PersicoPiero Luigi Almasio
Jun 7, 2008·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Francy Y E CarrilloJosé M Cuevas
Mar 24, 2007·Journal of Substance Abuse Treatment·Alain H LitwinJulia H Arnsten
Mar 11, 2006·Infectious Disease Clinics of North America·Amrita Sethi, Mitchell L Shiffman
Feb 1, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jordan J Feld, T Jake Liang
Mar 22, 2005·Journal of Hepatology·Robert ThimmeHubert E Blum
Feb 17, 2006·Drug and Alcohol Dependence·Markus BackmundJens Reimer
Dec 15, 2005·Journal of Hepatology·Giovanni B GaetaAntonella D'Arminio Monforte
May 1, 2015·AIDS Research and Human Retroviruses·Jean Claude DusingizeKathryn Anastos
Apr 19, 2011·Best Practice & Research. Clinical Gastroenterology·Vincenza Calvaruso, Antonio Craxì
Jan 8, 2013·Mathematical Biosciences·Hasifa NampalaCelestino Obua
Feb 8, 2006·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Juan Cristina
Sep 12, 2006·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Wenkui LiFrancis L S Tse
Oct 23, 2012·Journal of the International Association of Providers of AIDS Care·Rena MaimaitiRune Andersson
Jan 11, 2013·Liver International : Official Journal of the International Association for the Study of the Liver·Gamal EsmatMaisa El Raziky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

© 2021 Meta ULC. All rights reserved